Primary Biliary Cirrhosis
Top Cited Papers
- 22 September 2005
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (12) , 1261-1273
- https://doi.org/10.1056/nejmra043898
Abstract
Primary biliary cirrhosis, a slowly progressive autoimmune liver disease characterized by portal inflammation and an immune-mediated destruction of the intrahepatic bile ducts, leads to decreased bile secretion and the retention of toxic substances within the liver. This review considers new data concerning both the autoimmune responses involved and the treatment of primary biliary cirrhosis.Keywords
This publication has 94 references indexed in Scilit:
- A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: Ten-year resultsHepatology, 2004
- 112 The primary biliary cirrhosis (PBC) ursodiol (UDCA) plus methotrexate (MTX) or its placebo study (pumps) - A multicenter randomized trialHepatology, 2003
- Quantitative and functional analysis of PDC-E2–specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosisJournal of Clinical Investigation, 2002
- The Effect of Ursodeoxycholic Acid Therapy on Liver Fibrosis Progression in Primary Biliary CirrhosisHepatology, 2000
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Incidence of Cancer in Primary Biliary Cirrhosis: the Mayo ExperienceHepatology, 1999
- Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot studyJournal of Hepatology, 1994
- The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosisJournal of Hepatology, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- A Prospective Trial of Colchicine for Primary Biliary CirrhosisNew England Journal of Medicine, 1986